Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies

ClinicalTrials.gov ID: NCT05225415

Public ClinicalTrials.gov record NCT05225415. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 1:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Phase 2, 6-month Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Multi-center, randomized, double-blind, placebo-controlled, 6- month study in subjects with mild to moderate Dementia with Lewy Bodies.

Study identification

NCT ID
NCT05225415
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cognition Therapeutics
Industry
Enrollment
130 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 19, 2022 (Actual)
Primary completion
Nov 25, 2024 (Actual)
Completion
Nov 25, 2024 (Actual)
Last update posted
Mar 12, 2026

2022 – 2024

United States locations

U.S. sites
34
U.S. states
19
U.S. cities
31
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona 85013 —
Banner Sun Health Research Institute Sun City Arizona 85351 —
University of Arizona - Health Sciences Center Tucson Arizona 85724 —
Stanford University Palo Alto California 94304 —
Pacific Neuroscience Institute Santa Monica California 90404 —
University of Colorado Aurora Colorado 80045 —
CenExel Rocky Mountain Clinical Research, LLC Englewood Colorado 80113 —
New England Institute for Neurology and Headache (NEINH) Stamford Connecticut 06905 —
JEM Research Institute Atlantis Florida 33462 —
University of Miami Miller School of Medicine Comprehensive Center for Brain Health Boca Raton Florida 33433 —
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486 —
Charter Research Lady Lake Florida 32156 —
Renstar Medical Research Ocala Florida 34770 —
Charter Research Winter Park Florida 32792 —
Rush University Medical Center Section of Parkinson Disease and Movement Disorder Chicago Illinois 60612 —
IU Health Neuroscience Center, Goodman Hall Indianapolis Indiana 46202 —
Josephson Wallack Munshower Neurology, P.C Indianapolis Indiana 46256 —
The University of Kansas Alzheimer's Disease Research Center Fairway Kansas 66205 —
University of Kentucky Lexington Kentucky 40504 —
Headlands Research Eastern Massachusetts, LLC Plymouth Massachusetts 02360 —
Mayo Clinic Rochester Minnesota 55905 —
Columbia University New York New York 10032 —
UNC Department of Neurology Chapel Hill North Carolina 27599 —
Cleveland Clinic Main Campus Cleveland Ohio 44195 —
Ohio State University Columbus Ohio 43210 —
Summit Headlands, LLC Portland Oregon 97210 —
Oregon Health and Science University Portland Oregon 97239 —
University of Pennsylvania Philadelphia Pennsylvania 19107 —
University of Texas Southwestern Dallas Texas 75390 —
Clinical Trial Network Houston Texas 77074 —
University of Virginia Adult Neurology Charlottesville Virginia 22903 —
Virginia Commonwealth University Richmond Virginia 23298 —
Evergreen Health Research Kirkland Washington 98034 —
Universtiy of Washington Department of Neurology Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05225415, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05225415 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →